| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |